Legal action aims to protect Medicare coverage for radiation therapy.
- Skincure Oncology targets Medicare coverage changes.
- Seeks legal action to preserve patient access to treatment.
- Focus on image-guided superficial radiation therapy.
Skincure Oncology has initiated legal proceedings by requesting a federal court injunction to halt what it describes as unlawful efforts to remove Medicare coverage for image-guided superficial radiation therapy. This therapy is an important treatment option for patients with non-melanoma skin cancer, which is a common form of cancer and impacts a significant number of individuals annually. The company emphasizes that keeping this coverage is crucial for patient access to necessary treatment.
In its court filing, Skincure Oncology argues that the removal of Medicare coverage would negatively impact patients who rely on this type of radiation therapy. The company claims that the adjustments to coverage not only threaten patient care but could also disrupt the long-standing relationship between healthcare providers and patients seeking effective treatment options. By pursuing legal action, Skincure hopes to maintain essential healthcare support for affected individuals.
The ongoing dispute highlights the significant role Medicare plays in providing coverage for various forms of cancer treatment, including superficial radiation therapy. Skincure Oncology’s action serves to underscore the importance of ensuring that patients have access to treatments that meet their healthcare needs without the burden of increased out-of-pocket costs.
